Legal Representation
Attorney
Devasena Reddy
USPTO Deadlines
Next Deadline
1298 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-02-19)
Due Date
February 19, 2029
Grace Period Ends
August 19, 2029
Application History
47 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 8, 2025 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
Jul 3, 2025 | EWOR | I | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | Loading... |
Jul 3, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Jul 3, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Jul 3, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jul 3, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jul 3, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jul 3, 2025 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
Feb 19, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
May 2, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
May 2, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
May 2, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
May 2, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
May 2, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Feb 19, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Jan 17, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Jan 16, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Jan 15, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Jan 11, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Jan 11, 2019 | IUAF | S | USE AMENDMENT FILED | Loading... |
Sep 11, 2018 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
Sep 11, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Sep 10, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Sep 10, 2018 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
Sep 10, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Aug 13, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Aug 13, 2018 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
Aug 13, 2018 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
Aug 13, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 27, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jan 2, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jan 2, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Dec 13, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Nov 28, 2017 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
Nov 17, 2017 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
Nov 9, 2017 | ALIE | A | ASSIGNED TO LIE | Loading... |
Oct 29, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 27, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 26, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 26, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Oct 5, 2017 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
Oct 5, 2017 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
Oct 5, 2017 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
Oct 3, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 15, 2017 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Jul 14, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jul 11, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and medical preparations for the treatment of arthritis, autoimmune diseases, the immune system, the respiratory system, musculoskeletal system, genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, in gynecology and urology, for use in gastroenterology, and antibacterials, anti-virals, antibiotics and anti-fungals for the treatment of viral and bacterial infections; pharmaceutical preparations for the treatment of central precocious puberty; pharmaceutical delivery systems comprising implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the palliative treatment of advanced prostate cancer; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a variety of pharmaceuticals; pharmaceutical preparations for the treatment of cancer; drug delivery systems, namely, drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer; pharmaceutical delivery systems comprising an active pharmaceutical ingredient in a biodegradable polymer for the continuous release of a wide variety of therapeutic agents
First Use Anywhere:
Nov 19, 2018
First Use in Commerce:
Nov 19, 2018
Class 010
Medical devices, namely, implantable subcutaneous drug delivery devices sold empty; implantable subcutaneous drug delivery devices sold empty but used in the treatment of cancer; medical apparatus, namely, injection devices for pharmaceuticals
First Use Anywhere:
Nov 7, 2018
First Use in Commerce:
Nov 7, 2018
Additional Information
Design Mark
The mark consists of a stylized letter "T" in a circle. The circle is divided horizontally by a transparent band as the horizontal top portion of the letter "T", with the top half of the circle having a black outline with part of the left portion of the circle in dark gray and the remaining right potion in light gray. The lower half of the circle is divided by a vertical transparent band as the bottom vertical portion of the letter "T", with the circle being divided by the band into two parts, both being red. The color white represents background, outlining, shading and/or transparent areas and is not part of the mark.
Color Claim
The color(s) red, dark gray, light gray and black is/are claimed as a feature of the mark.
Classification
International Classes
005
010